From Synthesis to Mechanism: Biological Evaluation of a p-Toluidine-Based Thiazolidinone-Quinoline VEGFR-2 Candidate Supported by CADD
International Journal of Molecular Sciences · 26.03.2026 · 27 (7) · 3018
DOI: 10.3390/ijms27073018 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.03.2026. Verfasst von Emad Manni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Antineoplastic Agents, Quinolines, Protein Kinase Inhibitors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Deanship of Graduate Studies and Scientific Research at Jouf University, The Deanship of Graduate Studies and Scientific Research at Jouf University https://ror.org/02zsyt821.
Abstract (Originalsprache)
In response to recent advances in computer-aided drug discovery (CADD) enabled by high-performance computing, computational approaches were employed to support and rationalize the investigation of a VEGFR-2-targeted anticancer candidate, combining molecular-level modeling with experimental validation. Initial in silico ADMET profiling and molecular docking were conducted to support the evaluation of drug-like properties and target engagement within a series of para-toluidine-based derivatives (1–14). The most biologically active compound was further evaluated through 100 ns molecular dynamics simulations and comprehensive DFT calculations to investigate binding stability and electronic characteristics. Based on a rational design strategy and supported by computational analyses, the compounds were synthesized and fully characterized using IR, MS, 1H/13C NMR, and elemental analysis. Biological evaluation was performed against HepG-2, MCF-7, HCT-116, and normal WI-38 cells. Mechanistic studies included VEGFR-2 inhibition, wound-healing migration assays, cell-cycle distribution analysis, apoptosis assessment, and caspase-3 activation. Several derivatives exhibited micromolar cytotoxic activity, with compound 14 emerging as the most active against HepG-2 cells (IC50 = 7.84 ± 0.5 µM), showing cytotoxic activity comparable to that of sorafenib (IC50 = 9.18 ± 0.6 µM) and demonstrating favorable selectivity toward normal WI-38 cells (IC50 = 67.75 ± 3.6 µM). Compound 14 showed moderate VEGFR-2 inhibitory activity (IC50 = 0.55 µM), significant suppression of cell migration, pronounced G0/G1 cell-cycle arrest, and robust apoptosis induction supported by caspase-3 activation. Molecular docking and MD simulations supported a stable binding mode within the VEGFR-2 active site. This integrated framework highlights compound 14 as a selectively active VEGFR-2-oriented anticancer candidate scaffold with a favorable selectivity profile, supported by experimental and computational analyses, warranting further lead optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia.
- Chemistry Department, College of Science, Jouf University, P.O. Box 2014, Sakaka 72341, Saudi Arabia.
- Chemistry Department, Faculty of Science, Menoufia University, Shebin El-Kom 32511, Egypt.
- Photochemistry Department, National Research Centre, Dokki, Giza 12622, Egypt.
- Microbial Genetics Department, Biotechnology Research Institute, National Research Centre, Giza 12622, Egypt.
- Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo 11517, Egypt.
ORCID-Profile: Modather F Hussein, Wael A El-Sayed, Ahmed F El-Sayed, Hagar S El-Hema
Förderung
- The Deanship of Graduate Studies and Scientific Research at Jouf University
- The Deanship of Graduate Studies and Scientific Research at Jouf University https://ror.org/02zsyt821
Zitieren
APA
Manni, E., Hussein, M. F., Elkady, S., Abdel-Rahman, A. A., Hawata, M. A., El-Sayed, W. A., El-Sayed, A. F., & El-Hema, H. S. (2026). From Synthesis to Mechanism: Biological Evaluation of a p-Toluidine-Based Thiazolidinone-Quinoline VEGFR-2 Candidate Supported by CADD. International Journal of Molecular Sciences, 27(7), 3018. https://doi.org/10.3390/ijms27073018
Vancouver
Manni E, Hussein MF, Elkady S, Abdel-Rahman AA, Hawata MA, El-Sayed WA, et al. From Synthesis to Mechanism: Biological Evaluation of a p-Toluidine-Based Thiazolidinone-Quinoline VEGFR-2 Candidate Supported by CADD. International Journal of Molecular Sciences. 2026;27(7):3018. doi:10.3390/ijms27073018
BibTeX
@article{Manni2026,
author = {Manni, Emad and Hussein, Modather F and Elkady, Sara and Abdel-Rahman, Adel A-H and Hawata, Mohamed A and El-Sayed, Wael A and El-Sayed, Ahmed F and El-Hema, Hagar S},
title = {From Synthesis to Mechanism: Biological Evaluation of a p-Toluidine-Based Thiazolidinone-Quinoline VEGFR-2 Candidate Supported by CADD},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3018},
doi = {10.3390/ijms27073018}
}
EUVIMED